BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35714449)

  • 21. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
    Lu F; Gao Y; Li E
    Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology.
    Zhao K; Zhang H; Cui J; Zhang Y; Zhou T; Long B
    Stem Cell Res; 2023 Dec; 73():103255. PubMed ID: 37992565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a DKK1 homozygous knockout human embryonic stem cell line WAe001-A-21 using CRISPR/Cas9.
    Yang Z; Yuan F; Wang N; Liu Y; Zhang J; Wei R; Wu F; Wu Y; You K; Chen Y; Yang F; Li YX
    Stem Cell Res; 2021 Mar; 51():102161. PubMed ID: 33461039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
    Saeedi M; Ebrahim-Habibi A; Haghighi A; Zarrabi F; Amoli MM; Robati RM
    Biomed Res Int; 2014; 2014():653724. PubMed ID: 25054142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system.
    Wu X; Wang X
    Stem Cell Res; 2023 Jun; 69():103082. PubMed ID: 36963213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9.
    Yuan F; Guo D; Gao G; Liu Y; Xu Y; Wu Y; Yang F; Ke X; Lai K; Hong L; Li YX
    Stem Cell Res; 2017 Oct; 24():89-93. PubMed ID: 29034901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A homozygous Keap1-knockout human embryonic stem cell line generated using CRISPR/Cas9 mediates gene targeting.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():52-54. PubMed ID: 28413007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
    Wu F; Li X; Bai R; Li Y; Gao J; Lan F
    Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a human embryonic stem cell line (WAe009-A-78) carrying homozygous TBX18 knockout.
    Xu Q; Zhao T; Zhang Y; Fan W; Yan Y; Lan F
    Stem Cell Res; 2022 Jul; 62():102804. PubMed ID: 35533514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a homozygous ALX1 knockout human embryonic stem cell line (WAe001-A-060) by a CRISPR/Cas9 system.
    Xiao X; Chen Y; Peng L; Zhang T
    Stem Cell Res; 2021 May; 53():102309. PubMed ID: 33799274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing.
    Xie L; Huang J; Li X; Dai L; Lin X; Zhang J; Luo J; Zhang W
    Stem Cell Res; 2019 Dec; 41():101610. PubMed ID: 31775087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a homozygous P4HA2 knockout human embryonic stem cell line (FDCHDPe012-A) by CRISPR/Cas9 system.
    You J; Ma S; Zhang H; Chen L
    Stem Cell Res; 2022 Oct; 64():102930. PubMed ID: 36206672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9.
    Wang X; Sun J; Fu C; Liu C
    Stem Cell Res; 2023 Jun; 69():103077. PubMed ID: 36965407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
    Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
    Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a homozygous LRPAP1 knockout human embryonic stem cell line (FDCHDPe009-B) by CRISPR/Cas9 system.
    You J; Xi H; Ma S; Yang XJ; Chen L
    Stem Cell Res; 2021 Oct; 56():102516. PubMed ID: 34469777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing.
    Giri S; Purushottam M; Viswanath B; Muddashetty RS
    Stem Cell Res; 2019 Aug; 39():101494. PubMed ID: 31280136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
    Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
    Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
    Sun W; Li X; Dong J; Zhou Y
    Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout.
    de Toledo MAS; Fu X; Kluge F; Götz K; Schmitz S; Wanek P; Schüler HM; Pannen K; Chatain N; Koschmieder S; Brümmendorf TH; Zenke M
    Stem Cell Res; 2022 Apr; 60():102732. PubMed ID: 35279545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.